Navigation Links
CardioDynamics Agrees to be Acquired by SonoSite for $1.35 Per Share
Date:6/9/2009

as legal counsel to CardioDynamics. GCA Savvian acted as financial advisor and Fenwick & West LLP acted as legal counsel to SonoSite.

About CardioDynamics

CardioDynamics (www.cdic.com), the ICG Company, is the innovator and leader of an important medical technology called Impedance Cardiography (ICG). The Company develops, manufactures and markets noninvasive ICG diagnostic and monitoring devices and markets proprietary ICG sensors. The Company's ICG Systems are being used by physicians around the world to help battle the number one killer of men and women -- cardiovascular disease. Partners include GE Healthcare, Philips Medical Systems and Mindray.

About SonoSite

SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The company employs approximately 700 people worldwide.

Additional Information About the Transaction

This announcement is neither a solicitation of a proxy, an offer to purchase, nor a solicitation of an offer to sell, shares of CardioDynamics. In connection with the proposed transaction, CardioDynamics will file a proxy statement with the Securities and Exchange Commission (SEC). The definitive proxy materials will contain important information regarding the merger, including, among other things, the recommendation of CardioDynamics' Board of Directors with respect to the merger. INVESTORS ARE URGED TO READ THE PROXY STATEMENT WHEN IT BECOMES AVAILABLE BECAUSE IT WILL
'/>"/>

SOURCE CardioDynamics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase
2. CardioDynamics BioZ(R) ICG Technology Integrates with General Electric Healthcares Centricity(R) Electronic Medical Record (EMR) System
3. CardioDynamics Shareholders Approve One-for-Seven Reverse Split of Companys Common Stock and Trading in Post-split Shares Begins May 9, 2008
4. CardioDynamics Receives Nasdaq Letter of Non-Compliance With Minimum Bid Price Requirement
5. CardioDynamics BioZ(R) ICG Technology Featured in American College of Cardiology (ACC) Audio Series
6. CardioDynamics Ranked in Deloittes Technology Fast 50 Program for San Diego
7. CardioDynamics Receives FDA 510(k) Clearance for Innovative Clinical Parameters and Electronic Medical Record Compatibility
8. CardioDynamics Provides 2007 Shareholder Meeting Update
9. MannKind Agrees with Pfizer on the Purchase of Frankfurt Insulin Manufacturing Plant
10. PharmaNet Development Group Agrees to be Acquired by JLL Partners
11. AEterna Zentaris Agrees to Sell Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Cambridge Semantics, the leading provider of ... named in the recent ‘Hype Cycle for Life Sciences ... report details key insights pertaining to the benefits in ... analysts Michael Shanler and Stephen Davies, “The use of ... relationships with scientific stakeholders, and support collaboration and innovation ...
(Date:9/23/2014)... 23, 2014 Marktech Optoelectronics has introduced ... violet emitters in the 280 nm wavelength range. This ... which range from 280nm to 405nm. These new devices ... as well as curing. Mark Campito, Marktech’s CEO states ... interest to manufacturers is that we offer it in ...
(Date:9/23/2014)... 23, 2014 New spin-out ... Innovations, Cambridge Innovation Capital and Johnson & Johnson ... genomics company focused on harnessing the potential of ... testing and treatment, today announced it has raised ... Innovations and including Cambridge Innovation Capital and Johnson ...
(Date:9/22/2014)... 2014 Research and Markets ... the "Global Biotechnology Reagents Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769) Biotechnology reagents are chemical compounds ... to detect and examine another substance to provide ... laboratories to prepare, collect, and examine specimens from ...
Breaking Biology Technology:Cambridge Semantics Identified in Gartner’s ‘Hype Cycle for Life Sciences 2014’ Report 2Marktech Introduces its New Line of Deep UV Emitters 2Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 2Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 3Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 4Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 2Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 3
... leaders from across California,s life sciences industry will converge ... by Patients on March 8-9. The conference focus is ... and collaborative research. For the first time, ... California,s life sciences companies. CALBIO2012: Driven by Patients will ...
... VIEW, Calif., March 7, 2012  Today, Cobalt ... n-butanol, announced the achievement of major progress toward ... process. Cobalt in cooperation with ANDRITZ , ... plants for the pulp and paper industry, tested ...
... 2012 Karyopharm Therapeutics Inc., a leader in the ... covering its Selective Inhibitors of Nuclear Export (SINE), oral ... March 31 – April 4, 2012, in Chicago.  The ... use of Karyopharm,s novel SINE, along with Karyopharm scientists, ...
Cached Biology Technology:First Statewide Biotech Meeting Focuses on Patient Access, Innovation 2Cobalt Technologies Hits Key Commercial Milestone with Pretreatment Process Demonstration 2Cobalt Technologies Hits Key Commercial Milestone with Pretreatment Process Demonstration 3Karyopharm Therapeutics Announces Multiple Presentations on Selective Inhibitors of Nuclear Export (SINE) in Solid and Hematologic Malignancy Models and Spontaneous Canine Cancers at the American Association of Cancer Research (AACR) Meeting 2Karyopharm Therapeutics Announces Multiple Presentations on Selective Inhibitors of Nuclear Export (SINE) in Solid and Hematologic Malignancy Models and Spontaneous Canine Cancers at the American Association of Cancer Research (AACR) Meeting 3
(Date:9/22/2014)... 7,000 geoscientists will gather in Vancouver, British Columbia, Canada, ... America,s 126th Annual Meeting & Exposition on 19-22 October ... transportation of crude oil, earthquake prediction problems, and how ... and Tribulations of Life on an Active Subduction Zone, ... , A broad range of topics will be presented ...
(Date:9/21/2014)... dioxide emissions, the main contributor to global warming, are set ... of 40 billion tonnes. , The 2.5 per cent projected ... Carbon Project, which is co-led in the UK by researchers ... University of East Anglia and the College of Engineering, Mathematics ... comes ahead of the New York Climate Summit, where world ...
(Date:9/21/2014)... mussels and barnacles secrete very sticky proteins that help ... Inspired by these natural adhesives, a team of MIT ... to repair ships or help heal wounds and surgical ... MIT researchers engineered bacteria to produce a hybrid material ... a bacterial protein found in biofilms slimy layers ...
Breaking Biology News(10 mins):Geoscience topics in the spotlight -- Vancouver, BC 2Geoscience topics in the spotlight -- Vancouver, BC 3Geoscience topics in the spotlight -- Vancouver, BC 4Geoscience topics in the spotlight -- Vancouver, BC 5CO2 emissions set to reach new 40 billion ton record high in 2014 2CO2 emissions set to reach new 40 billion ton record high in 2014 3Engineered proteins stick like glue -- even in water 2Engineered proteins stick like glue -- even in water 3
... - Researchers are developing new technologies that combine ... and tiny particles such as bacteria, viruses and ... drug manufacturing to food safety. The technologies ... "lab-on-a-chip" applications, or miniature instruments that perform measurements ...
... shown that, from the time that a woman starts trying ... on the time to pregnancy. Professor Roger Hart told ... and Embryology that the negative effect of gum disease on ... effect of obesity. Periodontal (gum) disease is a ...
... to the deserts of East Africa and has unique physical traits ... It has a lack of pain sensation in its skin ... underground with limited oxygen supply. For the first ... understand its longevity and resistance to diseases of ageing. Researchers ...
Cached Biology News:Laser, electric fields combined for new 'lab-on-chip' technologies 2Laser, electric fields combined for new 'lab-on-chip' technologies 3Gum disease can increase the time it takes to become pregnant 2Gum disease can increase the time it takes to become pregnant 3Scientists sequence DNA of cancer-resistant rodent 2
MHC Volumes 1 & 2...
Hucal Agx Antigen Expression Service Specificity: Hucal Agx ...
MitoScreen (JC-1) Kit , 100 tests Consult technical datasheet for details....
Large-fragment, single-stranded carrier DNA of the highest quality, perfectly suited for all types of yeast transformation....
Biology Products: